Dear Robin, Gilead Sciences, Inc. is pleased to offer you the position of Senior Vice President and Chief Financial Officer reporting directly to me. Ms. Washington was previously Chief Financial Officer of Hyperion Solutions, which was acquired by Oracle Corporation in March 2007. Robin Washington. currently, robin l. washington holds the position of advisory board at altas partners inc, managing director at gilead sciences gmbh and chief financial officer for kite pharma, inc. ms. washington is also member-presidents council at the university of michigan, member-visitors board at graziadio school of business & management and chief Robin Washington was appointed director of GILEAD SCIENCES INTERNATIONAL LTD. on 16 December 2011, and its principal business activity is 82990 - Other business support service . Gilead Sciences (GILD-2.02%) announced its fourth-quarter and full-year 2016 results after the market closed on Tuesday. Robin Washington. Gilead Sciences Inc. said its Chief Financial Officer Robin Washington is retiring next year. We are very excited about you joining Gilead in this key leadership role, and we look forward to the prospect of working with you. Ms. Washington will continue as EVP and CFO while the company works to identify a successor. Robin was the Executive Vice President and Chief Financial Officer of Gilead Sciences, Inc., a biopharmaceutical company, since February 2014. Robin Wright and Clement Giraudet on a . Ms. Washington joined Gilead in 2008 and is currently Executive Vice President and Chief Financial Officer overseeing the company's finance, information technology and investor relations organizations. Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Robin Washington, Executive Vice President (EVP) and Chief Financial Officer (CFO), plans to retire from her role, effective March 1, 2020.Ms. Ms. Washington is the former executive vice president and chief financial officer for Gilead Sciences, Inc. Ms. Washington has over 30 years of experience as a . A seasoned executive with deep leadership and financial experience . Washington will continue as EVP and CFO while the company works to identify a successor. Robin Washington served as Executive Vice President and Chief Financial Officer of Gilead Sciences, which develops innovative medicines to improve the care of patients with life-threatening diseases. Robin L. Washington. . Sharon McCollam of Best Buy ($7million, left) and Robin Washington of Gilead Sciences ($6.2million, right)) were next on the list that was compiled by executive compensation firm Equilar and the AP Previously, Robin served in . Ms. Washington will report to John F. Milligan, PhD, Gilead's Chief Operating Officer. Patrick Thomas. Washington was previously Chief Financial Officer of Hyperion Solutions, which was acquired by Oracle Corporation in March 2007. Ms. Washington joined Gilead, a global biopharmaceutical company, in 2008 and is currently Executive Vice President and Chief Financial Officer where she oversees the Finance and Information Technology organizations.Ms. Executive Vice President and Chief Financial Offic Management Gilead Portugal. Gilead's longtime finance chief Robin Washington plans to step down next spring, retiring from a role she's held at the biotech for more than a decade. Robin Washington corporate profile, background and performance evaluation including other Gilead Sciences executives Germany Switzerland Spain Poland Netherlands Greece France Ireland Italy Belgium Austria HONEYWELL NOMINATES ROBIN WASHINGTON, CFO GILEAD SCIENCES, FOR BOARD OF DIRECTORS . FOSTER CITY, Calif.-- (BUSINESS WIRE)--April 21, 2008--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that Robin L. Washington will join the company in May 2008 as Senior Vice President and Chief Financial Officer. Pharma Gilead Pharmaceuticals United States of America. Ms. Senior Vice President and Chief Financial Officer @ Gilead Sciences Board Member @ Audit Committee Chair & Board Member salesforce.com Education: 1993 - 1995 Master of Business Administration in Finance @ Pepperdine Graziadio Business School 1980 - 1984 Bachelor of Business Administration in . Biography. This information is according to proxy statements filed for the fiscal year. Robin has been the Executive Vice President and Chief Financial Officer of Gilead Sciences, Inc., a biopharmaceutical company, since February 2014. Washington, a greater Detroit native, is a renowned industry leader with deep experience as an advisor for tech and life science companies. So I think there is a . Articles by Robin Washington on Muck Rack. Ahead of releasing its first-quarter results on Thursday, Gilead disclosed yet another senior executive departure: longtime CFO Robin Washington, who unveiled plans to exit come March 2020. Robin Washington, Gilead's Senior Vice President and Chief Financial Officer, will provide an overview of the company at the Citi conference on Tuesday, February 26 at 11:05 a.m. Eastern Time (ET . Robin L. Washington is currently a member of the Board of Directors of Alphabet, Inc., Honeywell International, Inc., and Salesforce.com. Ms. Washington joined Gilead in 2008 as Senior Vice President and Chief Financial Officer where she oversees the Global Finance and Information Technology organizations. The following outlines the specific terms of . Gilead Sciences Inc. undefined said late Tuesday Chief Financial Officer Robin Washington plans to retire in March 2020. Ms. Washington joined Gilead in 2008 as Senior Vice President and Chief Financial Officer where she oversees the Global Finance and Information Technology organizations. Robin Washington is the director of 2 companies. Meanwhile, 10 other senior executives have departed the business in just two years . Robin Washington, Gilead's CFO, stated during the company's Q1 earnings conference call in early May that "2018 is a trough year for us on which we can grow." . LinkedIn is the world's largest business network, helping professionals like Robin Washington discover inside connections to . Prior to Gilead, Ms. Washington was the Chief Financial Officer of Hyperion Solutions Inc. from 2006 - 2007, an enterprise software company that was acquired by Oracle Corporation in 2007. Prior to joining Gilead, she served as Chief Financial Officer of Hyperion Solutions, an enterprise software company. She served as Vice President and Chief Financial Officer of Gilead Sciences, Inc. from May 2008 until November 2019, where she oversaw Global Finance, Facilities and Operations, Investor Relations and the . Robin served as Executive Vice President and Chief Financial Officer of Gilead Sciences, Inc., from May 2008 - November 2019 where she oversaw Global Finance, Facilities and Operations, Investor Relations and the Information Technology organizations. Prior to Gilead, Ms. Washington was the CFO at Hyperion Solutions Inc. from 2005-2007. The company followed up, as usual, with a conference call with analysts to . She also served as Senior . Fortune 500 Rank: 118 Washington joined Gilead in 2008 and serves as executive vice president and CFO. Robin L. Washington is the Executive Vice President and Chief Financial Officer of Gilead Sciences, Inc., overseeing the Investor Relations, Global Finance a. Most recently she exercised 426 units of GOOG stock worth $1,198,764 on 22 February 2022.. Work Experience. Biography. Ms. Gilead Sciences Inc. undefined said late Tuesday Chief Financial Officer Robin Washington plans to retire in March 2020. Background on Robin Washington? Her term concludes on December 31, 2025. In . From January 2006 to June 2007, Robin served as Chief Financial Officer of Hyperion Solutions, an enterprise . Join us in celebrating the story of a black female leader, Robin Washington, and her long, purposeful career of mentorship and sponsorship of women . Ms. Washington served as an advisor to Gilead Sciences, Inc., a biopharmaceutical company, from November 2019 to March 2020. Washington was previously Chief Financial Officer of Hyperion Solutions, which was acquired by Oracle Corporation in March 2007. Washington is currently the Senior Vice President and Chief Financial Officer of Gilead Sciences, Inc., which she joined in 2008.? Robin Washington's email & phone number . Gilead Sciences just got a new CEO in Daniel O'Day, . MORRIS TOWNSHIP, N.J. - March 1, 2013 - Honeywell (NYSE: HON) announced today that Robin Washington, 50, Senior Vice President and Chief Financial Officer, Gilead Sciences, Inc., has been nominated for election to its Board of Directors at the April 22, 2013 annual meeting of shareowners. Gilead Sciences has found a new chief financial officer in an appointment that has mergers and acquisitions written all over it. April 30, 2019 6:03 pm ET. He has made documentaries about the civil rights movement and the lives of African Americans in the United States . She oversees the company's finance, information-technology, The plot features a dystopia following a Second American Civil War wherein a theonomic . The largest trade she's ever made was exercising 61,750 units of Alphabet Inc stock on 17 September 2012 worth over $3,223,350. Of this total $0 was received as a salary, $0 was received as a bonus, $0 was received in stock options, $0 was awarded as stock and $0 came from other types of compensation. Quick Take: Gilead Sciences CFO Robin Washington. Director, Alphabet, Honeywell, Vertiv Robin Washington has served as a Director since September 2013. Robin joined Gilead Sciences, Inc. (NASDAQ: GILD) in 2008 as Senior Vice President and Chief Financial Officer, and expanded her role to include operational responsibilities as Executive Vice . 02 2022 Outlook: 4 Charts to Watch 03 2022 M&A Outlook: Deal Market Expected to Continue Hot Pace 04 Robin Washington is CFO and Executive VP of Gilead Sciences. Three Bay Area women who led large health-focused organizations ex-Gilead Sciences CFO Robin Washington, former Ancestry President and CEO Margo Georgiadis and Livongo Health's ex-president . By Hannah Norman - Reporter, San Francisco Business Times May 1, 2019 Updated May 1, 2019, 2:17pm PDT Foster City-based Gilead Sciences' longtime chief financial officer is planning her exit. BACK TO MAIN MENU Company Statements Discount For Ambisome Gilead 2017 Year in Review 100 Corporate Equality Score Emergency Disaster Response Gilead Year in Review 2016 Top Corporate Philanthropist HIV Medicines Reach 10 Million People Discover Study Of FTAF For PrEP Corporate Responsibility Report 2015 Gilead Supports PrEP Education . A longtime senior editor, columnist, radio host and documentarian across mainstream and . Robin. Robin has made over 67 trades of the Alphabet Inc stock since 2011, according to the Form 4 filled with the SEC. Robin Washington served as Executive Vice President and Chief Financial Officer of Gilead Sciences, which develops innovative medicines to improve the care of patients with life-threatening diseases. She joined Gilead as SVP and CFO in 2008 and served as its EVP and CFO from February 2014 to November 2019. Text. . Washington was previously Chief Financial Officer of Hyperion Solutions, which was acquired by Oracle Corporation in March 2007. Robin Washington previously served as Executive Vice President and Chief Financial Officer of Gilead Sciences, which develops innovative medicines to improve the care of patients with life . Robin Washington | Strategic Adviser & Board Member | robin.washington@gilead.com | United States | CXOreach is an online B2B Database & Business Intelligence website. Ms. Washington was promoted to Executive Vice President in 2014. A biotech finance chief shares her thoughts on the CFO role. Robin Washington was appointed director of GILEAD SCIENCES LTD on 16 December 2011, and its principal business activity is 46460 - Wholesale of pharmaceutical goods . Executive Vice President and Chief Financial Offic Management Gilead Portugal. Robin L. Washington joined the Financial Accounting Foundation (FAF) Board of Trustees on January 1, 2021. FOSTER CITY, Calif. -- (BUSINESS WIRE)--Apr. Ms. Washington joined Gilead, a global biopharmaceutical company, in 2008 and is currently Executive Vice President and Chief Financial Officer where she oversees the Finance and Information Technology organizations.Ms. Date Headline (link) Source Relevant Snippet; 5/10/2021: Altas Partners Welcomes Robin Washington to Advisory Board | Business Wire: Business Wire: TORONTO- Altas Partners (AuAltasAu), a long-term oriented private equity investment firm, today announced the appointment of Robin Washington to the firmAos Advisory Board. She discusses her role in supporting Gilead's global expansion and how she has strengthened finance's ability to partner with the business by working closely with R&D and commercial operations to align the . Robin Wright was snapped in a steamy beach makeout session with her husband Clement Giraudet amid news of her ex Sean Penn's divorce from Leila George. Ms. Washington joined Gilead in 2008 as Senior Vice President and Chief Financial Officer where she oversees the Global Finance and Information Technology organizations. Washington has served as a member of our Board of Directors since April 2019. Altas Partners ("Altas"), a long-term oriented private equity investment firm, today announced the appointment of Robin Washington to the firm's Advis. Robin Washington, Gilead's CFO of 11 years, left only 27 days earlier to join Google parent Alphabet's board. The independent selection panel of the 12th Annual Bay Area CFO of the Year Awards is proud to announce their 2017 Hall of Fame Lifetime Achievement Award Join us in celebrating the story of a black female leader, Robin Washington, and her long, purposeful career of mentorship and sponsorship of women . 30, 2019-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Robin Washington, Executive Vice President (EVP) and Chief Financial Officer (CFO), plans to retire from her role, effective March 1, 2020 . Prior to joining Gilead, Ms. Washington was Chief Financial Officer of Hyperion Solutions, which was acquired by Oracle Corporation in March 2007. She joined Gilead as Senior Vice President and Chief Financial Officer in May 2008. A search for a successor is underway, Gilead said in an April 30 statement , and has agreed to remain in an advisory capacity through the company's reporting of 2019 results should a replacement . Prior to that . Washington will continue as CFO. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support As a journalist and editor, he was worked for newspapers in Boston and Duluth, Minnesota, as well as for NPR. Separately, Ms. Washington will join the board . Should a CFO be named before March 1, 2020, Ms. Washington has agreed to remain in an advisory capacity . Gilead Sciences' Chief Financial Officer Robin Washington to Step Down in Early 2020 Published: Apr 30, 2019 FOSTER CITY, Calif.--( BUSINESS WIRE )-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Robin Washington, Executive Vice President (EVP) and Chief Financial Officer (CFO), plans to retire from her role, effective March 1, 2020. As at GILEAD SCIENCES INC, made $0 in total compensation. Robin Washington, an acclaimed veteran journalist based in Minnesota, is the Forward's Editor-at-Large. Robin Washington . She served as Vice President and Chief Financial Officer of Gilead Sciences, Inc. from May 2008 until November 2019, where she oversaw Global Finance, Facilities and Operations, Investor Relations, and the . Robin L Washington is Chief Development Officer at Catalyst Partners Acquisition Corp. See Robin L Washington's compensation, career history, education, & memberships. In addition to her avid board leadership, Robin most recently served as Executive Vice President, Chief Financial Officer of Gilead Sciences, a $30-billion, research-based biopharmaceutical company. Robin L. Washington is currently a member of the Board of Directors of Alphabet, Inc., Honeywell International, Inc., and Salesforce.com. ROBIN L. WASHINGTON COMPANYEVP & CFO, Gilead Sciences Inc.BOARDHoneywell International Inc., Alphabet Inc., Salesforce.com In addition to her avid board leadership, Robin most recently served as Executive Vice President, Chief Financial Officer of Gilead Sciences, a $30-billion, research-based biopharmaceutical company. Robin L. Washington is Executive Vice President and Chief Financial Officer of Gilead Sciences, Inc. where she oversees the Global Finance and Information Technology organizations. She joined Gilead as Senior Vice President and Chief Financial Officer in May 2008. Robin L. Washington has served as executive vice president and chief financial officer of Gilead Sciences, Inc., a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines to improve the care of patients with life-threatening diseases, since May 2008. United States Canada UK Hong Kong Japan Australia New Zealand. Dividends - World. Prior to Gilead, Robin was the Chief Financial Officer of Hyperion Solutions Inc. from 2005 - 2007. View Robin Washington's professional profile on LinkedIn. She served as executive vice president and CFO at Gilead . At least two teams of analysts . Previously, Robin served in . The Handmaid's Tale is an American dystopian television series created by Bruce Miller, based on the 1985 novel of the same name by Canadian author Margaret Atwood.The series was ordered by the streaming service Hulu as a straight-to-series order of 10 episodes, for which production began in late 2016. Prior to Gilead, she served as . For Robin Washington, CFO of Gilead Sciences, Inc., making finance a strategic partner as the biotech company expands globally starts with hiring and developing the right talent. Robin L. Washington is currently a member of the Board of Directors of Alphabet, Inc., Honeywell International, Inc., and Salesforce.com. Prior to joining Gilead, she served as Chief Financial Officer of Hyperion Solutions, an enterprise software company. Biography. FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Robin Washington, Executive Vice President (EVP) and Chief Financial Officer (CFO), plans to retire . Robin Washington is an American journalist and filmmaker, born in Chicago in 1956. Andrew Dickinson, who joined Gilead in 2016 as EVP of corporate development and strategy, will assume the CFO role on Nov. 1, taking over from retiring financial chief Robin Washington. Print. Kate O'Sullivan July 25, 2012. Ms. Washington GOOG stock SEC Form 4 insiders trading. Washington will continue as CFO. . The CFO Briefcase 01 2022 Regulatory Outlook: A Year of Big Developments? Robin Washington, Gilead Sciences, Inc. - EVP & CFO [39] So there's still 1 million -- I mean I think it was 50,000 -- 49,000 or so patients treated over 1 million elderly. Get the latest Pittsburgh local news, breaking news, sports, entertainment, weather and traffic, as well as national and international news, from the Pulitzer Prize-winning staff of the Pittsburgh Post-Gazette. Robin L. WashingtonBoard of Trustees. Find Robin Washington's email address, contact information, LinkedIn, Twitter, other social media and more. Robin L. Washington is currently a member of the Board of Directors of Alphabet, Inc. (parent company of Google), Honeywell International, Inc. and Salesforce.com, where she currently serves as chair of the audit committee. The biotech's longtime financial chief, Robin Washington, plans to retire next March, setting the stage for another big executive search. When she accepted the CFO job at biopharmaceutical company Gilead Sciences in 2008, however, Washington knew she was in for a much longer-term capital management challenge.